Search Results - "Stark, Jeffrey L"

Barriers to treatment optimization and achievement of patients' goals: perspectives from people living with rheumatoid arthritis enrolled in the ArthritisPower registry by Gavigan, Kelly, Nowell, W Benjamin, Serna, Mylene S, Stark, Jeffrey L, Yassine, Mohamed, Curtis, Jeffrey R

“…Few studies have investigated patients' own treatment goals in rheumatoid arthritis (RA). The objective of this real-world, cross-sectional study of US…”
Get full text

Impact of Disease Burden of Patients with Psoriasis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry by Blauvelt, Andrew, McLean, Robert R., Beaty, Silky W., Sima, Adam P., Low, Robert, Stark, Jeffrey L., McClung, Laura, Bagel, Jerry

“…Introduction Due to variable psoriasis symptoms, disease progression, and individual responses to therapy, patients may start, stop, or switch biologic…”
Get full text

Skin Clearance is Associated with Reduced Treatment Failure in Patients with Psoriasis: Real-World Evidence from the CorEvitas Psoriasis Registry by McLean, Robert R., Sima, Adam P., Beaty, Silky, Low, Robert, Spitzer, Rebecca L., Stark, Jeffrey L., Lesser, Elizabeth, Lee, Edward, Armstrong, April

“…Introduction Complete and near-complete skin clearance have become achievable treatment goals for patients with psoriasis receiving systemic biologic…”
Get full text

The Annual Diagnostic Prevalence of Ankylosing Spondylitis and Axial Spondyloarthritis in the United States Using Medicare and MarketScan Databases by Curtis, Jeffrey R., Winthrop, Kevin, Bohn, Rhonda L., Suruki, Robert, Siegel, Sarah, Stark, Jeffrey L., Xie, Fenglong, Yun, Huifeng, Chen, Lang, Deodhar, Atul

“…Objective The objective of this study was to investigate the diagnostic prevalence of ankylosing spondylitis (AS) and axial spondyloarthritis (axSpA) in the…”
Get full text

Opioid Use in Patients with Ankylosing Spondylitis Is Common in the United States: Outcomes of a Retrospective Cohort Study by Sloan, Victor S, Sheahan, Anna, Stark, Jeffrey L, Suruki, Robert Y

“…To assess the prevalence of chronic opioid use in patients with ankylosing spondylitis (AS), and to compare the characteristics of patients with and without…”
Get full text

Mental health outcomes in patients with moderate to severe psoriasis treated with bimekizumab: Analysis of phase 2/3 randomized trials by Blauvelt, Andrew, Armstrong, April, Merola, Joseph F., Strober, Bruce, de Cuyper, Dirk, Peterson, Luke, Davies, Owen, Stark, Jeffrey L., Lebwohl, Mark

“…Patients with psoriasis have increased risk of suicidal ideation and behavior (SIB) and depression. Bimekizumab, a biologic that inhibits interleukin (IL)-17A…”
Get full text

Opioid use surrounding diagnosis and follow-up in patients with ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis: Results from US claims databases by Sheahan, Anna, Anjohrin, Suzanne, Suruki, Robert, Stark, Jeffrey L., Sloan, Victor S.

“…Objective To describe patients’ use of opioids in the year preceding and year following new diagnosis of ankylosing spondylitis (AS), psoriatic arthritis…”
Get full text

Nonradiographic axial spondyloarthritis: expanding the spectrum of an old disease: A narrative review by Magrey, Marina, Schwartzman, Sergio, de Peyrecave, Natasha, Sloan, Victor S., Stark, Jeffrey L.

“…Nonradiographic axial spondyloarthritis (nr-axSpA) represents a distinct phenotype within the spectrum of axial spondyloarthritis (axSpA), which is…”
Get full text

Content validity of the ASQoL for use in a non-radiographic axial spondyloarthritis population: a qualitative study by Hwang, Mark C., Martin, Mona, Harris, Kristina, Geerdts, Philip, Stark, Jeffrey L., Reveille, John

“…Purpose The ankylosing spondylitis quality of life (ASQoL) instrument is widely used to assess health-related quality of life in patients with ankylosing…”
Get full text

Occurrence of Possible Rheumatologic Immune-Related Adverse Events (rh-irAEs) Associated with Immune Checkpoint Inhibitor (ICI) Therapy by Anjohrin, Suzanne, Sheahan, Anna, Suruki, Robert, Stark, Jeffrey L., Sloan, Victor S.

“…Introduction Current epidemiologic literature of rheumatologic immune-related adverse events (rh-irAEs) consists of clinical trials, case reports, or smaller,…”
Get full text

Su1809 PREGNANCY OUTCOMES IN CROHN'S DISEASE PATIENTS EXPOSED TO CERTOLIZUMAB PEGOL: SAFETY DATA FROM THE SECURE REGISTRY by Lichtenstein, Gary R., Lee, Scott D., Feagan, Brian G., Loftus, Edward V., Ng, Samson, Dehlin, Kaitlin, Quinn, Paul, Coarse, Jason, Rosario-Jansen, Theresa, Arendt, Catherine, Stark, Jeffrey L.

Get full text

Nonradiographic axial spondyloarthritis: expanding the spectrum of an old disease by Marina Magrey, MD, Sergio Schwartzman, MD, Natasha de Peyrecave, PhD, Victor S. Sloan, MD, Jeffrey L. Stark, MD

“…Nonradiographic axial spondyloarthritis (nr-axSpA) represents a distinct phenotype within the spectrum of axial spondyloarthritis (axSpA), which is…”
Get full text

Bimekizumab in Patients with Moderate to Severe Plaque Psoriasis: Analysis of Mental Health and Associated Disorders by Blauvelt, Andrew, Armstrong, April, Merola, Joseph F., Strober, Bruce, De Cuyper, Dirk, Peterson, Luke, Davies, Owen, Stark, Jeffrey L., Lebwohl, Mark

“…Introduction: Patients (pts) with psoriasis have a greater risk of depression and suicidality than the general population.1 Here, we report Week (Wk)16 and…”
Get full text